The M235T polymorphism in the angiotensinogen gene and atrial fibrillation: A meta-analysis

被引:5
作者
Wang, HuiXuan [1 ]
Teng, Yi [1 ]
Wang, Ke [1 ]
Xia, ZhengWu [1 ]
Tian, YuanYuan [1 ]
Li, CuiJuan [1 ]
机构
[1] Kunming Gen Hosp PLA, Dept Lab Med, Kunming, Peoples R China
基金
国家高技术研究发展计划(863计划);
关键词
Angiotensinogen; M235T; gene polymorphism; atrial fibrillation; meta-analysis; CONVERTING ENZYME; SYSTEM; POPULATION; INHIBITION; ANTAGONIST; HEART;
D O I
10.1177/1470320313513482
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective: The M235T polymorphism in the angiotensinogen gene has been reported to be associated with the development of atrial fibrillation (AF).However, results from observational studies are conflicting. Methods: PubMed, google scholar and China National Knowledge Infrastructure database(2000.1-2013.4) were searched for eligible articles; four separate studies with 2580 subjects on the relationship between M235T polymorphism and AF were analyzed by meta-analysis. The associations between M235T polymorphism and AF risk were estimated by pooled odds ratio (OR) and 95% confidence interval (CI) using a fixed or random-effects model. Results: There was a significant association between M235T polymorphism and AF. The pooled OR for the recessive model in the total population was 2.17 (95% CI: 1.39-3.38, I-2=0%). In a subgroup analysis by nationality, the pooled OR for TT vs. MM genotype was 0.55 (95% CI: 0.32-0.95, I-2=0%) and the pooled OR for the recessive model was 1.86 (95% CI: 1.08-3.20, I-2=0%) in Asians. Conclusions: The current meta-analysis suggested that the M235T polymorphism in the angiotensinogen gene might be related to the increased risk of AF in Asians. Conclusive evidence on the effects of the variants in AF should be addressed in further studies.
引用
收藏
页码:647 / 652
页数:6
相关论文
共 20 条
  • [1] Meta-analysis: Inhibition of renin-angiotensin system prevents new-onset atrial fibrillation
    Anand, Kishlay
    Mooss, Aryan N.
    Hee, Tom T.
    Mohiuddin, Syed M.
    [J]. AMERICAN HEART JOURNAL, 2006, 152 (02) : 217 - 222
  • [2] Detection of putative functional angiotensinogen (AGT) gene variants controlling plasma AGT levels by combined segregation-linkage analysis
    Brand, E
    Chatelain, N
    Paillard, F
    Tiret, L
    Visvikis, S
    Lathrop, M
    Soubrier, F
    Demenais, F
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 (11) : 715 - 723
  • [3] REMODELING OF THE RAT RIGHT-AND-LEFT-VENTRICLES IN EXPERIMENTAL-HYPERTENSION
    BRILLA, CG
    PICK, R
    TAN, LB
    JANICKI, JS
    WEBER, KT
    [J]. CIRCULATION RESEARCH, 1990, 67 (06) : 1355 - 1364
  • [4] Quantification of the power of Hardy-Weinberg equilibrium testing to detect genotyping error
    Cox, DG
    Kraft, P
    [J]. HUMAN HEREDITY, 2006, 61 (01) : 10 - 14
  • [5] Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation
    Goette, A
    Staack, T
    Röcken, C
    Arndt, M
    Geller, JC
    Huth, C
    Ansorge, S
    Klein, HU
    Lendeckel, U
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (06) : 1669 - 1677
  • [6] INHIBITION BY ANGIOTENSIN-II TYPE-1 RECEPTOR ANTAGONIST OF CARDIAC PHENOTYPIC MODULATION AFTER MYOCARDIAL-INFARCTION
    HANATANI, A
    YOSHIYAMA, M
    KIM, SK
    OMURA, T
    TODA, I
    AKIOKA, K
    TERAGAKI, M
    TAKEUCHI, K
    IWAO, H
    TAKEDA, T
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1995, 27 (09) : 1905 - 1914
  • [7] The impact of suppressing the renin-angiotensin system on atrial fibrillation
    Kalus, JS
    Coleman, CI
    White, CM
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (01) : 21 - 28
  • [8] Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure
    Li, DS
    Shinagawa, K
    Pang, L
    Leung, TK
    Cardin, S
    Wang, ZG
    Nattel, S
    [J]. CIRCULATION, 2001, 104 (21) : 2608 - 2614
  • [9] Genetics of Atrial Fibrillation Implications for Future Research Directions and Personalized Medicine
    Lubitz, Steven A.
    Ozcan, Cevher
    Magnani, Jared W.
    Kaeaeb, Stefan
    Benjamin, Emelia J.
    Ellinor, Patrick T.
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2010, 3 (03) : 291 - 299
  • [10] Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation
    Nakashima, H
    Kumagai, K
    Urata, H
    Gondo, N
    Ideishi, M
    Arakawa, K
    [J]. CIRCULATION, 2000, 101 (22) : 2612 - 2617